Bradykinin-induced dipsogenesis in captopril-treated rats

Area of Science:

• Physiology
• Pharmacology
• Neuroscience

Background:

• Bradykinin is a peptide involved in various physiological processes.
• The role of bradykinin in regulating thirst (dipsogenesis) is not fully understood.
• Angiotensin II (AII) is a known dipsogenic hormone, acting via specific receptors.

Purpose of the Study:

• To investigate the dipsogenic effect of bradykinin in rats.
• To determine if bradykinin-induced drinking is mediated by angiotensin II receptors.
• To explore the interaction between angiotensin I converting enzyme (ACE) inhibition and bradykinin's effects on water intake.

Main Methods:

• Male Sprague-Dawley rats were administered captopril (an ACE inhibitor) followed by saline or varying doses of bradykinin.
• Water intake and urine output were measured over two hours.
• The effect of an angiotensin II receptor antagonist (Sar) on bradykinin-induced drinking was assessed in rats treated with captopril and bradykinin.

Main Results:

• Bradykinin administration led to a dose-related increase in water intake.
• Bradykinin did not significantly affect urine output.
• The angiotensin II receptor antagonist did not block bradykinin-induced drinking in captopril-treated rats.
• ACE inhibition appeared to increase bradykinin's half-life and unmask its dipsogenic properties.

Conclusions:

• Bradykinin possesses intrinsic dipsogenic properties.
• Bradykinin-induced drinking is not mediated through angiotensin II receptors.
• Blocking angiotensin I converting enzyme enhances bradykinin's effect on water intake, suggesting a potential interaction or prolonged action of bradykinin.